Institute of Pathology, Alb Fils Clinics GmbH, Göppingen, Germany; Institute of Pathology, University Hospital Ulm, Ulm, Germany.
Center for Integrated Diagnostics, Department of Pathology, Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts.
Lab Invest. 2023 May;103(5):100062. doi: 10.1016/j.labinv.2023.100062. Epub 2023 Jan 18.
Tissue microarrays (TMA) have become an important tool in high-throughput molecular profiling of tissue samples in the translational research setting. Unfortunately, high-throughput profiling in small biopsy specimens or rare tumor samples (eg, orphan diseases or unusual tumors) is often precluded owing to limited amounts of tissue. To overcome these challenges, we devised a method that allows tissue transfer and construction of TMAs from individual 2- to 5-μm sections for subsequent molecular profiling. We named the technique slide-to-slide (STS) transfer, and it requires a series of chemical exposures (so-called xylene-methacrylate exchange) in combination with rehydrated lifting, microdissection of donor tissues into multiple small tissue fragments (methacrylate-tissue tiles), and subsequent remounting on separate recipient slides (STS array slide). We developed the STS technique by assessing the efficacy and analytical performance using the following key metrics: (a) dropout rate, (b) transfer efficacy, (c) success rates using different antigen-retrieval methods, (d) success rates of immunohistochemical stains, (e) fluorescent in situ hybridization success rates, and (f) DNA and (g) RNA extraction yields from single slides, which all functioned appropriately. The dropout rate ranged from 0.7% to 6.2%; however, we applied the same STS technique successfully to fill these dropouts ("rescue" transfer). Hematoxylin and eosin assessment of donor slides confirmed a transfer efficacy of >93%, depending on the size of the tissue (range, 76%-100%). Fluorescent in situ hybridization success rates and nucleic acid yields were comparable with those of traditional workflows. In this study, we present a quick, reliable, and cost-effective method that offers the key advantages of TMAs and other molecular techniques-even when tissue is sparse. The perspectives of this technology in biomedical sciences and clinical practice are promising, given that it allows laboratories to create more data with less tissue.
组织微阵列(TMA)已成为转化研究中高通量分子分析组织样本的重要工具。然而,由于组织量有限,通常无法对小活检标本或罕见肿瘤样本(例如孤儿病或不常见的肿瘤)进行高通量分析。为了克服这些挑战,我们设计了一种方法,可以在单个 2-5μm 切片上进行组织转移和 TMA 构建,以进行后续的分子分析。我们将该技术命名为玻片到玻片(STS)转移,它需要一系列化学暴露(所谓的二甲苯-甲基丙烯酸酯交换),结合再水化提升、将供体组织切成多个小块(甲基丙烯酸酯-组织小块),以及随后在单独的接收载玻片上重新安装(STS 阵列载玻片)。我们通过评估以下关键指标的有效性和分析性能来开发 STS 技术:(a)缺失率、(b)转移效率、(c)使用不同抗原回收方法的成功率、(d)免疫组织化学染色的成功率、(e)荧光原位杂交的成功率,以及(f)从单个载玻片提取的 DNA 和(g)RNA 的产量,所有这些功能都正常。缺失率范围为 0.7%至 6.2%;然而,我们应用相同的 STS 技术成功地填补了这些缺失(“救援”转移)。根据组织大小,供体载玻片的苏木精和伊红评估确认转移效率>93%(范围为 76%-100%)。荧光原位杂交成功率和核酸产量与传统工作流程相当。在这项研究中,我们提出了一种快速、可靠且具有成本效益的方法,即使在组织稀疏的情况下,也提供了 TMA 和其他分子技术的关键优势。鉴于该技术允许实验室用更少的组织生成更多的数据,因此它在生物医学科学和临床实践中的前景是有希望的。